| Breakdown | TTM | Apr 2024 | Apr 2023 | Oct 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.37M | 23.04M | 22.28M | 20.31M | 19.14M | 17.66M |
| Gross Profit | 10.05M | 9.38M | 8.59M | 7.64M | 6.42M | 6.63M |
| EBITDA | 2.83M | 2.42M | 2.23M | 1.49M | 34.00K | 1.00M |
| Net Income | 1.02M | 662.00K | 134.00K | 353.00K | -804.00K | 151.00K |
Balance Sheet | ||||||
| Total Assets | 16.43M | 16.15M | 16.65M | 18.53M | 16.18M | 15.78M |
| Cash, Cash Equivalents and Short-Term Investments | 386.00K | 344.00K | 1.14M | 581.00K | 157.00K | 484.00K |
| Total Debt | 4.36M | 4.01M | 4.87M | 5.94M | 5.41M | 3.67M |
| Total Liabilities | 7.72M | 7.48M | 8.53M | 10.60M | 8.61M | 7.55M |
| Stockholders Equity | 8.72M | 8.67M | 8.08M | 7.89M | 7.53M | 8.19M |
Cash Flow | ||||||
| Free Cash Flow | 1.06M | 1.25M | 2.15M | 927.00K | -2.07M | -697.00K |
| Operating Cash Flow | 1.58M | 1.80M | 3.00M | 1.79M | -745.00K | 319.00K |
| Investing Cash Flow | -1.05M | -1.01M | -834.00K | -830.00K | -1.30M | -1.02M |
| Financing Cash Flow | -179.00K | -1.43M | -1.62M | -504.00K | 1.49M | 520.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £9.05M | -38.26 | 7.90% | ― | 3.41% | 393.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £9.84M | 13.62 | 4.23% | 3.20% | 10.26% | 45.18% | |
61 Neutral | £6.83M | -4.01 | -8.19% | ― | 63.81% | 71.62% | |
44 Neutral | £1.85M | -6.65 | -21.12% | ― | -43.45% | -240.00% | |
42 Neutral | £4.13M | -0.42 | -76.54% | ― | -21.55% | 10.59% |